Fierce Pharma19h
Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis
Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
Endocrinology Advisor1d
FDA Approves Losartan Oral Suspension Arbli
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...
Novartis1d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
FDA approves Xeris Biopharma’s sNDA of Gvoke VialDx as gastro diagnostic aid
Holdings announced that its supplemental new drug application, sNDA, of Gvoke VialDx has received U.S Food and Drug ...
STAT21h
Pharmalittle: We’re reading about possible HIV prevention cuts, FDA warning an African drugmaker, and more
The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...
JD Supra17h
FDA Directed to Explore Elimination of Food Additive "Loophole"
Secretary Kennedy seeks to enhance FDA's oversight of food additives by eliminating a pathway that allows new ingredients to be introduced into ...
Travere Therapeutics submits sNDA to FDA for approval of FILSPARI in FSGS
Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...
Neurology Advisor20h
FDA Fast Tracks Investigational Nonopioid Treatment for Acute Pain
The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.
pharmaphorum1d
FDA approves Herceptin biosimilar as US patent expires
The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...
The Hill6d
Here’s where Trump’s approval rating stands on key issues
Analysts said it’s not a given that Trump’s approval will fully drop underwater, but recent historical trends indicate a frustration that sets in with sitting presidents after a grace period.
Daily Post Nigeria6d
Zamfara Gov approves two key appointments
Governor Dauda Lawal of Zamfara State has approved the appointment of two new Executive Secretaries to the Zamfara State Electricity Agency, ZAEA, and Zamfara Geographic Information System ...
The Hill4d
Concerns over economic chaos are weighing on Trump’s approval rating
Trump’s approval may continue to take a hit. To be sure, Trump is not even two months into a four-year term. There is plenty of time for these numbers to improve, especially if the ...